Dehydrozingerone, chalcone, and isoeugenol analogues as in vitro anticancer agents.
Jin Tatsuzaki, Kenneth F Bastow, Kyoko Nakagawa-Goto, Seiko Nakamura, Hideji Itokawa, Kuo-Hsiung Lee
Index: J. Nat. Prod. 69 , 1445-9, (2006)
Full Text: HTML
Abstract
Twenty-eight compounds related to dehydrozingerone (1), isoeugenol (3), and 2-hydroxychalcone (4) were synthesized and evaluated in vitro against human tumor cell replication. Except for isoeugenol analogues 27-35, most compounds exhibited moderate or strong cytotoxic activity against KB, KB-VCR (a multidrug-resistant derivative), and A549 cell lines. In particular, chalcone 15 showed significant cytotoxic activity against the A549 cell line with an IC50 value of 0.6 microg/mL. Furthermore, dehydrozingerone analogue 11 and chalcones 16 and 17 showed significant and similar cytotoxic activity against both KB (IC50 values of 2.0, 1.0, and 2.0 microg/mL, respectively) and KB-VCR (IC50 values of 1.9, 1.0, and 2.0 microg/mL, respectively) cells, suggesting that they are not substrates for the P-glycoprotein drug efflux pump.
Related Compounds
Related Articles:
2013-01-01
[Sci. Rep. 3 , 1220, (2013)]
2010-11-01
[Nat. Prod. Res. 24(19) , 1807-10, (2010)]
2009-08-01
[Br. J. Dermatol. 161(2) , 489-90, (2009)]
2004-01-14
[EMBO J. 23(1) , 120-6, (2004)]
1983-06-01
[J. Dermatol. 10(3) , 241-50, (1983)]